OneSource Specialty Pharma Live Share Price Today, Share Analysis and Chart

Name: OneSource Specialty Pharma Ltd.: Is Infosys Ltd. worth buying?
Item: OneSource Specialty Pharma Ltd.
Rating: 1.535458375
Author: Trendlyne DVM scores

Momentum Trap

about

OneSource Specialty Pharma Ltd. (ONESOURCE) is a multimodal pure-play specialty pharmaceutical Contract Development and Manufacturing Organisation (CDMO). The company provides end-to-end services across advanced technology platforms and therapeutic m...

1654.30 -17.20 (-1.03%)

56.51% Gain from 52W Low

177.5K

NSE+BSE Volume

NSE 23 Jul, 2026 3:31 PM (IST)

Board Meeting

The next board meeting for OneSource Specialty Pharma is on 24 Jul 2026 for the purpose of Quarterly Results See details

Loading... You have run out of DVM views!

Subscribe now to see details

Low Financial Strength

- / 100

Expensive Valuation

- / 100

Technically Neutral

55.7 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

2,037

1Yr Price target upside is 23%

4 analysts

OneSource Specialty Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

OneSource Specialty Pharma Live Share Price Today, Share Analysis and Chart

OneSource Specialty Pharma Ltd. (ONESOURCE) is a multimodal pure-play specialty pharmaceutical Contract Development and Manufacturing Organisation (CDMO). The company provides end-to-end services across advanced technology platforms and therapeutic m...

56.51% Gain from 52W Low

SWOT Analysis

OneSource Specialty Pharma Live Price Chart

OneSource Specialty Pharma Live Price Chart